Chiarito, Mauro
Sanz-Sanchez, Jorge
Piccolo, Raffaele
Condello, Francesco
Liccardo, Gaetano
Maurina, Matteo
Avvedimento, Marisa
Regazzoli, Damiano
Pagnotta, Paolo
Garcia-Garcia, Hector M.
Mehran, Roxana
Federici, Massimo
Condorelli, Gianluigi
Diez Gil, Jose Luis
Reimers, Bernhard
Ferrante, Giuseppe
Stefanini, Giulio
Clinical trials referenced in this document:
Documents that mention this clinical trial
Safety of metformin continuation in diabetic patients undergoing invasive coronary angiography: the NO-STOP single arm trial
https://doi.org/10.1186/s12933-023-01744-4
Article History
Received: 29 August 2022
Accepted: 16 January 2023
First Online: 6 February 2023
Declarations
:
: The study complies with the Declaration of Helsinki and was approved by the Ethics Committee of Humanitas Clinical and Research Hospital.
: Not required.
: Dr. Garcia-Garcia reports the following institutional grant support: Biotronik, Boston Scientific, Medtronic, Abbott, Neovasc, Shockwave, Phillips, and Corflow. Dr. Mehran reports grants from Abbott Laboratories, AstraZeneca, Bayer, Beth Israel Deaconess, Bristol Myers Squibb, CSL Behring, DSI, Medtronic, Novartis Pharmaceuticals, OrbusNeich; personal fees from Abbott Laboratories, Boston Scientific, Medscape/WebMD, Siemens Medical Solutions, PLx Opco Inc/dba PLx Pharma Inc, Roivant Sciences, Sanofi, Medtelligence (Janssen Scientific Affairs), Janssen Scientific Affairs; other from Abbott laboratories, other from Abiomed, other from Bristol Myers Squibb, other from Claret Medical, other from Elixir Medical, other from The Medicines eCompany, other from Spectranetics/Philips/Volcano Corp, other from Watermark Research Partners; non-financial support and other from Regeneron Pharmaceuticals, Idorsia Pharmaceuticals Ltd. Dr. Reimers has received speaker honoraria from Boston Scientific. Dr. Stefanini reports a research grant from Boston Scientific and speaker or consulting fees from B. Braun, Biosensors, and Boston Scientific. All other authors report no relationships relevant to the contents of this paper to disclose.
: Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.